Tumor cells can regulate the LD content via the EGFR–PI3K–mTOR and FOXO/SIRT6 pathways, and LDs also regulate the proliferation and growth of tumor cells via membrane lipid and energy formation [69–74], which establishes a tight association between LDs and tumor cells. The gene discussed is MTOR; the disease is neoplasm.